NYSE:CSLT - Castlight Health Stock Price, Forecast & News

Castlight Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CSLT."

Castlight Health Inc (NYSE:CSLT) posted its quarterly earnings data on Thursday, October, 24th. The software maker reported ($0.04) EPS for the quarter, hitting analysts' consensus estimates of ($0.04). The software maker had revenue of $35.46 million for the quarter, compared to analyst estimates of $35.46 million. Castlight Health had a negative return on equity of 13.00% and a negative net margin of 21.68%. The firm's revenue was down 11.4% compared to the same quarter last year. View Castlight Health's Earnings History.

Castlight Health is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Castlight Health.

Castlight Health will be holding an earnings conference call on Tuesday, February 25th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Castlight Health issued an update on its FY 2019 After-Hours earnings guidance on Thursday, January, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $145 million, compared to the consensus revenue estimate of $142.26 million.

3 equities research analysts have issued 1-year target prices for Castlight Health's shares. Their forecasts range from $1.20 to $1.50. On average, they anticipate Castlight Health's stock price to reach $1.35 in the next year. This suggests a possible upside of 8.0% from the stock's current price. View Analyst Price Targets for Castlight Health.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Castlight Health in the last year. There are currently 1 sell rating and 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Castlight Health.

Media stories about CSLT stock have been trending very negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Castlight Health earned a daily sentiment score of -3.5 on InfoTrie's scale. They also assigned news stories about the software maker a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Castlight Health.

Castlight Health saw a drop in short interest in the month of January. As of January 31st, there was short interest totalling 1,530,000 shares, a drop of 6.1% from the January 15th total of 1,630,000 shares. Based on an average daily trading volume, of 813,400 shares, the days-to-cover ratio is currently 1.9 days. Approximately 1.5% of the company's stock are short sold. View Castlight Health's Current Options Chain.

Some companies that are related to Castlight Health include Cars.com (CARS), Tucows (TCX), Liberty Tripadvisor Holdings Inc Series A (LTRPA), Sohu.com (SOHU), ZIX (ZIXI), CooTek (Cayman) (CTK), GTY Technology (GTYH), Brightcove (BCOV), Ooma (OOMA), Fang (SFUN), NantHealth (NH), Park City Group (PCYG), FRONTEO (FTEO), Akerna (KERN) and Veritone (VERI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Castlight Health investors own include Gilead Sciences (GILD), Corbus Pharmaceuticals (CRBP), FireEye (FEYE), Ford Motor (F), Verizon Communications (VZ), Weyerhaeuser (WY), Akorn (AKRX), Advanced Micro Devices (AMD), Avid Technology (AVID) and Abraxas Petroleum (AXAS).

Castlight Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include FMR LLC (11.39%), Oak Management Corp (2.03%), Gagnon Securities LLC (1.99%), Renaissance Technologies LLC (1.57%), State Street Corp (1.25%) and Jacobs Levy Equity Management Inc. (0.55%). Company insiders that own Castlight Health stock include John C Doyle, Maeve O'meara, Mangini Siobhan Nolan, MP Eric Chan, Neeraj Gupta, Seth B Cohen and William Bondurant. View Institutional Ownership Trends for Castlight Health.

CSLT stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Oak Management Corp, Penbrook Management LLC, Panagora Asset Management Inc., Edge Wealth Management LLC, Bank of New York Mellon Corp, Gagnon Securities LLC and Bank of America Corp DE. Company insiders that have sold Castlight Health company stock in the last year include John C Doyle, Maeve O'meara, Mangini Siobhan Nolan, MP Eric Chan, Neeraj Gupta and William Bondurant. View Insider Buying and Selling for Castlight Health.

CSLT stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Jacobs Levy Equity Management Inc., Goldman Sachs Group Inc., FMR LLC, UBS Group AG, Acadian Asset Management LLC, Barclays PLC and Russell Investments Group Ltd.. View Insider Buying and Selling for Castlight Health.

Shares of CSLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CSLT stock can currently be purchased for approximately $1.25.

Castlight Health has a market capitalization of $182.71 million and generates $156.40 million in revenue each year. The software maker earns $-39,710,000.00 in net income (profit) each year or ($0.16) on an earnings per share basis. Castlight Health employs 470 workers across the globe.View Additional Information About Castlight Health.

The official website for Castlight Health is http://www.castlighthealth.com/.

Castlight Health's mailing address is 150 SPEAR STREET SUITE 400, SAN FRANCISCO CA, 94105. The software maker can be reached via phone at 415-829-1400 or via email at [email protected]